Guidance language has shifted from projecting growth to reaffirming specific 2026 financial targets, including an 8% SUBLOCADE net revenue growth midpoint and 30% adjusted EBITDA growth. Strategic ...

Indivior Pharmaceuticals, Inc. ( INDV) Q4 2025 Earnings Call February 26, 2026 8:00 AM EST Good morning, everyone. I am joined today by Joe Ciaffoni, Chief Executive Officer; Pat Barry, Chief ...